» Articles » PMID: 23094723

Patients' Expectations About Effects of Chemotherapy for Advanced Cancer

Overview
Journal N Engl J Med
Specialty General Medicine
Date 2012 Oct 26
PMID 23094723
Citations 403
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Chemotherapy for metastatic lung or colorectal cancer can prolong life by weeks or months and may provide palliation, but it is not curative.

Methods: We studied 1193 patients participating in the Cancer Care Outcomes Research and Surveillance (CanCORS) study (a national, prospective, observational cohort study) who were alive 4 months after diagnosis and received chemotherapy for newly diagnosed metastatic (stage IV) lung or colorectal cancer. We sought to characterize the prevalence of the expectation that chemotherapy might be curative and to identify the clinical, sociodemographic, and health-system factors associated with this expectation. Data were obtained from a patient survey by professional interviewers in addition to a comprehensive review of medical records.

Results: Overall, 69% of patients with lung cancer and 81% of those with colorectal cancer did not report understanding that chemotherapy was not at all likely to cure their cancer. In multivariable logistic regression, the risk of reporting inaccurate beliefs about chemotherapy was higher among patients with colorectal cancer, as compared with those with lung cancer (odds ratio, 1.75; 95% confidence interval [CI], 1.29 to 2.37); among nonwhite and Hispanic patients, as compared with non-Hispanic white patients (odds ratio for Hispanic patients, 2.82; 95% CI, 1.51 to 5.27; odds ratio for black patients, 2.93; 95% CI, 1.80 to 4.78); and among patients who rated their communication with their physician very favorably, as compared with less favorably (odds ratio for highest third vs. lowest third, 1.90; 95% CI, 1.33 to 2.72). Educational level, functional status, and the patient's role in decision making were not associated with such inaccurate beliefs about chemotherapy.

Conclusions: Many patients receiving chemotherapy for incurable cancers may not understand that chemotherapy is unlikely to be curative, which could compromise their ability to make informed treatment decisions that are consonant with their preferences. Physicians may be able to improve patients' understanding, but this may come at the cost of patients' satisfaction with them. (Funded by the National Cancer Institute and others.).

Citing Articles

The UK's Early Access to Medicines Scheme 10 years on: an evaluation using publicly available data.

Pound P, Ram R, Archibald K JRSM Open. 2025; 16(2):20542704251317916.

PMID: 40007990 PMC: 11848878. DOI: 10.1177/20542704251317916.


Do We Have a Knowledge Gap with Our Patients?-On the Problems of Knowledge Transfer and the Implications at the End of Life.

Heuser N, Heers H, Gschnell M, Urhahn F, Schrade S, Volberg C Int J Environ Res Public Health. 2025; 22(2).

PMID: 40003472 PMC: 11855585. DOI: 10.3390/ijerph22020247.


Contemporary Patterns of End-of-Life Care Among Medicare Beneficiaries With Advanced Cancer.

Kwon Y, Hu X, Shi K, Zhao J, Jiang C, Fan Q JAMA Health Forum. 2025; 6(2):e245436.

PMID: 39982714 PMC: 11846012. DOI: 10.1001/jamahealthforum.2024.5436.


Assessment Tools to Examine Illness Understanding in Patients with Advanced Cancer: A Systematic Review of Randomized Clinical Trials.

Tu A, de la Rosa A, Krause K, Brown J, Hui D Cancers (Basel). 2025; 17(3).

PMID: 39941754 PMC: 11816152. DOI: 10.3390/cancers17030385.


Responsive cancer care in Asia: stigma and pain must be acknowledged and addressed.

Andres E, Poco L, Balasubramanian I, Chaudhry I, Ozdemir S, Manalo M Support Care Cancer. 2025; 33(2):128.

PMID: 39883219 DOI: 10.1007/s00520-025-09173-7.


References
1.
Smith T, Hillner B . Explaining marginal benefits to patients, when "marginal" means additional but not necessarily small. Clin Cancer Res. 2010; 16(24):5981-6. DOI: 10.1158/1078-0432.CCR-10-1278. View

2.
Hays R, Shaul J, Williams V, Lubalin J, Sweeny S, Cleary P . Psychometric properties of the CAHPS 1.0 survey measures. Consumer Assessment of Health Plans Study. Med Care. 1999; 37(3 Suppl):MS22-31. DOI: 10.1097/00005650-199903001-00003. View

3.
Gattellari M, Voigt K, Butow P, Tattersall M . When the treatment goal is not cure: are cancer patients equipped to make informed decisions?. J Clin Oncol. 2002; 20(2):503-13. DOI: 10.1200/JCO.2002.20.2.503. View

4.
Ayanian J, Zaslavsky A, Arora N, Kahn K, Malin J, Ganz P . Patients' experiences with care for lung cancer and colorectal cancer: findings from the Cancer Care Outcomes Research and Surveillance Consortium. J Clin Oncol. 2010; 28(27):4154-61. PMC: 2953972. DOI: 10.1200/JCO.2009.27.3268. View

5.
Catalano P, Ayanian J, Weeks J, Kahn K, Landrum M, Zaslavsky A . Representativeness of participants in the cancer care outcomes research and surveillance consortium relative to the surveillance, epidemiology, and end results program. Med Care. 2012; 51(2):e9-15. PMC: 3654676. DOI: 10.1097/MLR.0b013e318222a711. View